Covaxin shot 78% effective against Covid, say developers
"I am very pleased to state that Covaxin ... has shown the efficacy of 78% in the second interim analysis," said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech
India's only domestically developed Covid-19 vaccine, Covaxin, has been found to be 78% effective in a second analysis of clinical trials done around the country, its makers said https://www.bharatbiotech.com/images/press/covaxin-phase3-clinical-trial... on Wednesday.
"I am very pleased to state that Covaxin ... has shown the efficacy of 78% in the second interim analysis," said Balram Bhargava, the chief of the state-run Indian Council of Medical Research that has created the vaccine with Bharat Biotech.
The first analysis released in March had shown an efficacy rate of 81%.
Keep updated, follow The Business Standard's Google news channel
